
Swab
Swab both nostrils using medium pressure. Insert the swab approximately 1/2″-3/4″ (no deeper) and make at least 5 circles, swabbing the inner sides of each nostril. Take approximately 15 seconds per nostril.
Plunge
Pour
ASSURE-100 Rapid COVID-19 Home Tests
Developed in Hawai’i by Oceanit, a cutting-edge technology company with a team of just 200 people, the ASSURE-100 was granted two FDA authorizations in 2022. These approvals allow the test to be used globally by healthcare professionals and at home without requiring a prescription, expanding access to critical diagnostic tools.
Founded in 1985 in Honolulu, Hawai’i, Oceanit has built a world-class reputation for groundbreaking science and disruptive innovation. Guided by core values of curiosity, community, and ohana (family), Oceanit’s team of scientists, engineers, and innovators addresses some of the world’s most complex challenges, including advancing solutions for the ongoing COVID-19 pandemic.

From Hawaii to the World.


The ASSURE-100 Rapid COVID-19 Test Kit, developed by Oceanit in Honolulu, Hawai‘i, USA, empowers communities to fight COVID-19 with fast, reliable testing. Designed for convenience and accuracy, the ASSURE-100 was granted two Emergency Use Authorizations (EUAs) by the U.S. Food and Drug Administration (FDA) in 2022:
For point-of-care use by healthcare professionals.
For over-the-counter (OTC) at-home use.
Oceanit, a Hawai‘i-based technology company, is dedicated to protecting communities from current and future COVID-19 outbreaks. By combining innovation with a deep commitment to public health, Oceanit continues to develop tools that prioritize safety and accessibility.
The ASSURE-100 Rapid Test Kit is available for purchase online, with options for local Hawai‘i delivery or pickup. For bulk orders, please contact us using the button below.
Self-test at home with ASSURE
This FDA-authorized test delivers accurate, reliable results in just 20 minutes, using a shallow nasal swab for improved comfort. With the ASSURE-100, taking control of your health has never been easier or more accessible.


Protect your Organization with ASSURE
The ASSURE-100 Rapid COVID-19 Test is straightforward and intuitive, consisting of just three components: a nasal swab, a solution vial, and a test cassette. This design enables organizations to implement testing programs with ease, protecting employees, clients, and communities.
Spread Aloha, Not Covid with the ASSURE-100 Rapid Covid-19 Test
Frequently Asked Questions
ASSURE-100 is a rapid COVID-19 test that uses an anterior nasal specimen to detect COVID-19, the disease caused by the SARS-CoV-2 virus. ASSURE is an acronym for: Accelerated Sensor Solution for Urgent Response to Epidemics.
” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}” parentOrderClass=”dsm_faq_0″][/dsm_faq_child][dsm_faq_child dsm_title=”2. Where was ASSURE-100 developed?” dsm_content=”
The ASSURE technology and ASSURE-100 rapid COVID-19 test was developed by Oceanit in Hawaiʻi and was put through testing and clinical trials in Hawaii and in other states across the US.
” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}” parentOrderClass=”dsm_faq_0″][/dsm_faq_child][dsm_faq_child dsm_title=”3. How do ASSURE tests work?” dsm_content=”ASSURE-100 uses shallow nasal specimens to detect COVID-19 using a lateral flow assay (LFA) test cassette. A shallow anterior nasal swab specimen is mixed with buffer solution and then poured into the well on the test cassette. ASSURE tests are visually read, and do not require an external device to interpret results.” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}” parentOrderClass=”dsm_faq_0″][/dsm_faq_child][dsm_faq_child dsm_title=”4. Does ASSURE-100 Rapid COVID-19 Home Test detect Omicron variants?” dsm_content=”Yes, the ASSURE-100 Rapid COVID-19 Home Test clinical trial included BA.2.12.1 and BA.2 variant samples. Additionally, the ASSURE-100 test was evaluated in a dilution series of clinical specimens positive for the Omicron variants BA.5 and BE.1. This testing was conducted by National Institutes of Health (NIH) as a component of the Rapid Acceleration of Diagnostics (RADx) initiative. Results indicate that ASSURE-100 detects both BA.5 and BE.1 variants.” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}” parentOrderClass=”dsm_faq_0″][/dsm_faq_child][dsm_faq_child dsm_title=”5. How quickly will ASSURE-100 detect a result if positive? ” dsm_content=”Results should be read at 20 minutes.” _builder_version=”4.27.4″ _module_preset=”default” global_colors_info=”{}” parentOrderClass=”dsm_faq_0″][/dsm_faq_child][/dsm_faq]
Get in touch via email
If you have any questions please contact us at info@assure-test.com or by clicking the button below. Alternatively, you can get in touch by filling the contact form.